Medication Guide App

Brintellix Approval History

  • FDA approved: Yes (First approved September 30th, 2013)
  • Brand name: Brintellix
  • Generic name: vortioxetine
  • Company: Takeda Pharmaceutical Company Limited and H. Lundbeck A/S
  • Treatment for: Depression, Major Depressive Disorder

Brintellix (vortioxetine) is a multimodal antidepressant for the treatment of major depressive disorder (MDD).

FDA Approval History for Brintellix

DateArticle
Sep 30, 2013Approval FDA Approves Brintellix to Treat Major Depressive Disorder
Dec 12, 2012FDA Accepts Takeda and Lundbeck's Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
Oct  1, 2012Takeda and Lundbeck Announce the U.S. Submission of a New Drug Application for Vortioxetine, an Investigational Drug for the Treatment of Major Depressive Disorder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)